Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Learn which dividend growth ETF is cheapest and how reducing costs can boost your net returns. Compare the options and pick the best value.
25,776 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Hudbay's 2025 earnings outlook hinges on copper and zinc markets, mine costs, and capital decisions. This guide break...
United Wholesale Mortgage's parent raises its 2026 revenue forecast just before a key Two Harbors Investment vote on ...
Circle’s ARC presale unlocks a $3 billion fully diluted valuation and signals a broader push into institutional finan...
Investors chased space-focused stocks higher on SpaceX IPO speculation, lifting Spacemobile 20%, Planet Labs 15%, and...
Defense technology is approaching a market shakeout as government procurement reforms accelerate purchases and ventur...
Investors are eyeing a potential rebound for Figma as enterprise adoption grows and AI-driven updates sharpen the pla...
June data show an ongoing existing home sales decline as prices reach a new record high, underscored by tighter suppl...
A growing cohort of retirees is exploring a 5.5% withdrawal strategy as market conditions and Social Security plannin...
Oro Labs has secured a $100 million Series C to scale its AI-powered procurement orchestration platform, expanding it...
Micron’s latest earnings and bold capex plans intensify the debate over whether the memory giant can achieve a trilli...
A global memory crunch has propelled Micron to the forefront of AI-era investing. This article breaks down the why, w...